As with other drugs, Revlimid can cause side effects, such as skin rash and constipation. Revlimid (lenalidomide) is approved by the Food and Drug Administration (FDA) to treat the following ...

Celgene's big-selling blood cancer drug Revlimid may cause a rare but potentially fatal skin reaction in some patients ... and discontinue the drug if a rash appears. According to the company ...

such as a mild rash, call your doctor right away. They may suggest a treatment to manage your symptoms and can determine whether you should keep taking Revlimid. If you have symptoms of a severe ...

Revlimid interruption or discontinuation should be considered for Grade 2-3 skin rash. It must be discontinued for angioedema ... or other Grade 3 or 4 toxicity judged to be related to Revlimid. For ...

In settlement of all outstanding claims related ... in the limbs, skin rash, and worsening of colitis. For full prescribing information, see package insert located here. REVLIMID ® is a ...

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl (NASDAQ: CELG) announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan’s Ministry of ...

The Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) with Velcade (bortezomib), Revlimid (lenalidomide ... peripheral edema, rash, infusion-related reaction, insomnia and ...

a skin disorder; and psoriatic arthritis, a related condition that causes pain and swelling of the joints. Summit, New-Jersey based Celgene has become one of the world's biggest biotechnology ...